- Potential benefitRaises public awareness of brain tumors, prompting outreach and education efforts.
- Potential benefitMay increase charitable donations to brain tumor research and patient support groups.
- Potential benefitSignals legislative attention that could help prioritize future research funding discussions.
A resolution designating May 2025 as "National Brain Tumor Awareness Month".
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2948; text: CR S2954-2955)
This resolution is a Senate simple resolution that names May 2025 as National Brain Tumor Awareness Month and expresses the Senate's support for awareness, research, patients, families, and collaborative research. It is nonbinding and symbolic, intended to raise public awareness and encourage outreach and research efforts. It does not create law, allocate funding, or require action by the President or federal agencies.
This Senate resolution designates May 2025 as "National Brain Tumor Awareness Month." It cites incidence, mortality, survival statistics, and challenges in treatment and research.
The resolution encourages public awareness, supports efforts to develop better treatments, expresses support for patients, families, and caregivers, and urges collaborative research.
It is a nonbinding, symbolic statement without appropriation or regulatory provisions.
Simple Senate resolutions are chamber-specific and do not create law; symbolic designation cannot become statute.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly states the problem and designates May 2025 as National Brain Tumor Awareness Month while encouraging awareness and research collaboration. Its nonbinding language and lack of fiscal, enforcement, or implementing detail are consistent with the typical form and function of such resolutions.
All favor designation, but differ on desire for federal funding
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenNon‑binding symbolic resolution does not appropriate funding or change legal authorities.
- Potential burdenLikely little direct effect on research timelines, approved treatments, or survival rates.
- Federal agenciesAny federal funding increases or programs would require separate legislation or appropriations.
Why the argument around this bill splits.
All favor designation, but differ on desire for federal funding
Likely strongly supportive; views the designation as a useful, noncontroversial way to raise awareness and highlight research gaps.
Will emphasize needs for equity in research, access to care, and federal investment to translate awareness into outcomes (not guaranteed by the text).
Generally favorable but pragmatic: views the resolution as a low-cost, bipartisan gesture to raise awareness.
Will note it is symbolic and that measurable progress requires concrete funding and targeted programs, which this text does not provide.
Likely supportive but views it as symbolic.
Will appreciate the focus on patients while noting the lack of new spending or federal mandates.
May prefer private-sector and nonprofit-led solutions over additional federal programs.
The path through Congress.
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Still ahead
Simple Senate resolutions are chamber-specific and do not create law; symbolic designation cannot become statute.
- Whether a companion House resolution will be introduced
- Public or advocacy attention could affect uptake
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
All favor designation, but differ on desire for federal funding
Simple Senate resolutions are chamber-specific and do not create law; symbolic designation cannot become statute.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly states the problem and designates May 2025 as National Brain Tumor Awareness Month while encouraging awaren…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.